Myc-enhanced expression of Cul1 promotes ubiquitin-dependent proteolysis and cell cycle progression

  1. Rónán C. O'Hagan1,2,
  2. Michael Ohh1,
  3. Gregory David1,2,
  4. Ignacio Moreno de Alboran4,5,
  5. Frederick W. Alt4,5,
  6. William G. Kaelin, Jr.1,3, and
  7. Ronald A. DePinho1,2,6
  1. 1Department of Adult Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115 USA; 2 Department of Medicine and Genetics, Harvard Medical School, Boston, Massachusetts 02115 USA; 3 Howard Hughes Medical Institute, Dana Farber Cancer Institute, Boston, Massachusetts 02115 USA; 4 Howard Hughes Medical Institute, Children's Hospital, Boston, Massachusetts 02115 USA; 5 Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115 USA

Abstract

The c-Myc oncoprotein plays an important role in the growth and proliferation of normal and neoplastic cells. To execute these actions, c-Myc is thought to regulate functionally diverse sets of genes that directly govern cellular mass and progression through critical cell cycle transitions. Here, we provide several lines of evidence that c-Myc promotes ubiquitin-dependent proteolysis by directly activating expression of the Cul1 gene, encoding a critical component of the ubiquitin ligase SCFSKP2. The cell cycle inhibitor p27kip1 is a known target of the SCFSKP2 complex, and Myc-induced Cul1 expression matched well with the kinetics of declining p27kip1 protein. Enforced Cul1 expression or antisense neutralization of p27kip1 was capable of overcoming the slow-growth phenotype of c-Myc null primary mouse embryonic fibroblasts (MEFs). In reconstitution assays, the addition of in vitro translated Cul1 protein alone was able to restore p27kip1ubiquitination and degradation in lysates derived fromc-myc −/− MEFs or density-arrested human fibroblasts. These functional and biochemical data provide a direct link between c-Myc transcriptional regulation and ubiquitin-mediated proteolysis and together support the view that c-Myc promotes G1 exit in part via Cul1-dependent ubiquitination and degradation of the CDK inhibitor, p27kip1.

Keywords

Footnotes

  • 6 Corresponding author.

  • E-MAIL ron_depinho{at}dfci.harvard.edu; FAX (617) 632-6069

  • Article and publication are at www.genesdev.org/cgi/doi/10.1101/gad.827200.

    • Received June 14, 2000.
    • Accepted July 10, 2000.
| Table of Contents

Life Science Alliance